NCT07691684

Brief Summary

This study looked at whether an injection into the jaw joint (temporomandibular joint, or TMJ) can help people who have pain, clicking, and difficulty opening their mouth due to a slipped joint disc. Thirty patients were randomly assigned to receive one of three injections: platelet-rich plasma (PRP, made from the patient's own blood), a steroid medication (dexamethasone) with a local anesthetic, or a saline (salt water) injection as a comparison. Pain, joint clicking, and mouth opening were measured before the injection and one week later. The study found that both PRP and the steroid injection reduced pain and clicking more than saline, and PRP also improved how wide patients could open their mouth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 9, 2026

Completed
Last Updated

July 9, 2026

Status Verified

July 1, 2026

Enrollment Period

4 months

First QC Date

July 2, 2026

Last Update Submit

July 2, 2026

Conditions

Keywords

DexamethasonePlatelet-Rich PlasmaIntra-articular InjectionTMJRandomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Intensity (VAS)

    Pain intensity rated on a 10-cm visual analogue scale (0=no pain, 10=worst imaginable pain), reflecting the most intense pain during function.

    Baseline and 1 week post-injection

Secondary Outcomes (2)

  • Change in Joint Sound (Clicking)

    Baseline and 1 week post-injection

  • Change in Maximum Interincisal Opening (MIO)

    Baseline and 1 week post-injection

Study Arms (3)

PRP

EXPERIMENTAL

Single intra-articular injection of 0.6 mL leukocyte-poor platelet-rich plasma (PRP) into the superior joint space via a preauricular approach.

Biological: Platelet-Rich Plasma (PRP)

Dexamethasone + Local Anaesthetic

ACTIVE COMPARATOR

Single intra-articular injection of dexamethasone 4 mg (0.5 mL) combined with lidocaine 2% (0.5 mL), total 1 mL, into the superior joint space.

Drug: Dexamethasone with Local Anaesthetic

Normal Saline (Control)

PLACEBO COMPARATOR

Single intra-articular injection of 1 mL sterile 0.9% sodium chloride into the superior joint space, replicating the full procedural experience without an active agent.

Other: Normal Saline (Placebo)

Interventions

Autologous platelet-rich plasma (1 mL) prepared from the patient's own venous blood by centrifugation, injected into the superior joint space of the temporomandibular joint under a standardised preauricular approach.

PRP

Intra-articular injection (1 mL) of dexamethasone combined with a local anaesthetic, delivered into the superior joint space of the temporomandibular joint using the same standardised preauricular approach as the other study arms.

Dexamethasone + Local Anaesthetic

Intra-articular injection (1 mL) of normal saline solution into the superior joint space of the temporomandibular joint, serving as the placebo control, using the same standardised preauricular approach as the other study arms.

Normal Saline (Control)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Skeletally mature patients aged 18 years or older
  • Symptomatic TMJ internal derangement in the form of disc displacement with reduction (DDwR), diagnosed using DC/TMD Axis I clinical criteria
  • TMJ arthralgia confirmed by pain reproduced on palpation or provoked by jaw movement
  • Clicking sound detectable on palpation or auscultation during opening and closing movements
  • Elimination or marked reduction of the click on mouth opening from a protruded position

You may not qualify if:

  • Intra-articular injection within the previous six months
  • Systemic inflammatory arthropathy
  • Coagulopathy
  • Active local infection
  • Low platelet count
  • Ongoing antiplatelet or anticoagulant therapy
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Dentistry, University of Anbar

Ramadi, Al Najaf, 54001, Iraq

Location

MeSH Terms

Conditions

Temporomandibular Joint DisordersTemporomandibular Joint Dysfunction Syndrome

Interventions

DexamethasoneAnesthesia, LocalSaline Solution

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesMyofascial Pain Syndromes

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedAnesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Sabah Alheeti, BDS, CABMS, FIBMS

    Oral and Maxillofacial Surgery Department / College of Dentistry / University of Anbar

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
"Outcome assessor was fully blinded throughout follow-up. Participants in the dexamethasone and saline arms were blinded to allocation; full blinding was not feasible in the PRP arm due to the visible blood-draw and processing procedure
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postgraduate Researcher

Study Record Dates

First Submitted

July 2, 2026

First Posted

July 9, 2026

Study Start

December 10, 2025

Primary Completion

April 9, 2026

Study Completion

April 9, 2026

Last Updated

July 9, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

"The dataset supporting the conclusions of this article may be requested from the corresponding author"

Locations